A Trial of Endostar in Patients With Carcinoma of the Head and Neck

PHASE2UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 20, 2017

Study Completion Date

January 31, 2019

Conditions
Nasopharyngeal Neoplasms
Interventions
DRUG

Endostar

The patients will be randomized to CRT arm and CRT+Endostar arm. All patients will receive one cycles of induction chemotherapy, intensity modulated radiation therapy (IMRT) with weekly cisplatin and 3 cycles of chemotherapy after IMRT.

Trial Locations (1)

410011

the Second Xiangya Hospital, Changsha

All Listed Sponsors
collaborator

Chinese Society of Clinical Oncology

OTHER

lead

China International Medical Foundation

OTHER